Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Paolicelli

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2006
The IFNbeta treatment of multiple sclerosis (MS) in clinical practice: the experience at the MS Center of Bari, ItalyM Trojano, D Paolicelli, G B Zimatore, et al.
Brain Research Bulletin|August 12, 2003
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-betaC Avolio, F Giuliani, G M Liuzzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 26, 2006
Italian Multiple Sclerosis Database NetworkM Trojano, D Paolicelli, V Lepore, et al.
The Journal of Urology|October 19, 1999
Varicocele: a multidisciplinary approach in children and adolescentsG Mazzoni, G Fiocca, S Minucci, et al.
Journal of Neuroimmunology|January 4, 2017
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patientsD Paolicelli, A Manni, M D'Onghia, et al.
Minerva Cardioangiologica|April 1, 1996
[Physical training and low-dose heparin-calcium in patients suffering from chronic obliterating arteriopathy of the lower limbs with intermittent claudication]G Cina, M Vernich, C Campisi, et al.
Neurology|October 26, 1999
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MSM Trojano, C Avolio, G M Liuzzi, et al.
Journal of the Neurological Sciences|June 8, 2024
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosingA Manni, F Oggiano, C Palazzo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 17, 2011
Multiple sclerosis in Italy: cost-of-illness studyF Patti, M P Amato, M Trojano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 24, 2017
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE studyA Ghezzi, A Bianchi, D Baroncini, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2006
The IFNbeta treatment of multiple sclerosis (MS) in clinical practice: the experience at the MS Center of Bari, ItalyM Trojano, D Paolicelli, G B Zimatore, et al.
Brain Research Bulletin|August 12, 2003
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-betaC Avolio, F Giuliani, G M Liuzzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 26, 2006
Italian Multiple Sclerosis Database NetworkM Trojano, D Paolicelli, V Lepore, et al.
The Journal of Urology|October 19, 1999
Varicocele: a multidisciplinary approach in children and adolescentsG Mazzoni, G Fiocca, S Minucci, et al.
Journal of Neuroimmunology|January 4, 2017
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patientsD Paolicelli, A Manni, M D'Onghia, et al.
Minerva Cardioangiologica|April 1, 1996
[Physical training and low-dose heparin-calcium in patients suffering from chronic obliterating arteriopathy of the lower limbs with intermittent claudication]G Cina, M Vernich, C Campisi, et al.
Neurology|October 26, 1999
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MSM Trojano, C Avolio, G M Liuzzi, et al.
Journal of the Neurological Sciences|June 8, 2024
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosingA Manni, F Oggiano, C Palazzo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 17, 2011
Multiple sclerosis in Italy: cost-of-illness studyF Patti, M P Amato, M Trojano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 24, 2017
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE studyA Ghezzi, A Bianchi, D Baroncini, et al.
Pageof 3